PL2408446T3 - Zastosowanie kompozycji farmaceutycznych zawierających mesembrenon - Google Patents

Zastosowanie kompozycji farmaceutycznych zawierających mesembrenon

Info

Publication number
PL2408446T3
PL2408446T3 PL10710448T PL10710448T PL2408446T3 PL 2408446 T3 PL2408446 T3 PL 2408446T3 PL 10710448 T PL10710448 T PL 10710448T PL 10710448 T PL10710448 T PL 10710448T PL 2408446 T3 PL2408446 T3 PL 2408446T3
Authority
PL
Poland
Prior art keywords
mesembrenone
pharmaceutical compositions
compositions containing
pharmaceutical
containing mesembrenone
Prior art date
Application number
PL10710448T
Other languages
English (en)
Inventor
Alan Harvey
Nigel Gericke
Alvaro Viljoen
Original Assignee
Hg&H Pharmaceuticals (Pty) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hg&H Pharmaceuticals (Pty) Limited filed Critical Hg&H Pharmaceuticals (Pty) Limited
Publication of PL2408446T3 publication Critical patent/PL2408446T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/36Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
PL10710448T 2009-03-20 2010-03-16 Zastosowanie kompozycji farmaceutycznych zawierających mesembrenon PL2408446T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ZA200902003 2009-03-20
EP10710448.1A EP2408446B1 (en) 2009-03-20 2010-03-16 Use of pharmaceutical compositions containing mesembrenone
PCT/IB2010/051132 WO2010106494A1 (en) 2009-03-20 2010-03-16 Use of pharmaceutical compositions containing mesembrenone

Publications (1)

Publication Number Publication Date
PL2408446T3 true PL2408446T3 (pl) 2020-03-31

Family

ID=42167479

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10710448T PL2408446T3 (pl) 2009-03-20 2010-03-16 Zastosowanie kompozycji farmaceutycznych zawierających mesembrenon

Country Status (9)

Country Link
US (1) US8552051B2 (pl)
EP (1) EP2408446B1 (pl)
AU (1) AU2010224485B2 (pl)
DK (1) DK2408446T3 (pl)
ES (1) ES2759675T3 (pl)
PL (1) PL2408446T3 (pl)
PT (1) PT2408446T (pl)
WO (1) WO2010106494A1 (pl)
ZA (1) ZA201106703B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2702461T3 (es) 2009-03-20 2019-03-01 Hg&H Pharmaceuticals Pty Ltd Extracto de Sceletium y usos del mismo
GB201101075D0 (en) 2011-01-21 2011-03-09 Labminds Ltd Automated solution dispenser
LT2672957T (lt) 2011-02-07 2017-02-10 Scipharm Sarl Naujoji kompozicija, skirta cistinės fibrozės gydymui
CN105121439A (zh) 2013-02-19 2015-12-02 辉瑞公司 作为pde4亚型抑制剂用于治疗cns和其他病症的氮杂苯并咪唑化合物
EP3049101A4 (en) 2013-09-27 2018-01-10 Sher, Justin Nutraceutical compositon for pde4 inhibition, enhanced dopamine metabolism and long term potentiation
US10179155B2 (en) 2014-02-28 2019-01-15 Nature's Sunshine Products, Inc. Phosphodiesterase-4 inhibiting phytochemical compositions
EP3172210B1 (en) 2014-07-24 2020-01-15 Pfizer Inc Pyrazolopyrimidine compounds
KR102061952B1 (ko) 2014-08-06 2020-01-02 화이자 인코포레이티드 이미다조피리다진 화합물
EP3254165B1 (en) 2015-02-06 2021-04-28 LabMinds Ltd Automated solution dispenser
WO2017089347A1 (en) 2015-11-25 2017-06-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas
US20200215033A1 (en) * 2017-07-26 2020-07-09 Hg&H Pharmaceuticals (Pty) Ltd Mesembrenol and/or mesembranol for prophylaxis and treatment of patients suffering from epilepsy and associated diseases
WO2021086345A1 (en) * 2019-10-30 2021-05-06 Plant Synergy Inc. High yield extraction method for and products of kanna plants
US10864239B1 (en) 2019-10-30 2020-12-15 Plant Synergy Inc. High yield extraction method for and products of kanna plants

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3604112A1 (de) 1986-02-10 1987-08-13 Bernhard Dr Janiak Pflanzenextrakte von mesembryanthemaceen sowie solche enthaltende schaedlingsbekaempfungsmittel und arzneimittel
US6271001B1 (en) 1995-03-23 2001-08-07 Bio Polymers Pty. Ltd. Cultured plant cell gums for food, pharmaceutical, cosmetic and industrial applications
ZA974576B (en) 1996-06-04 1998-02-04 Farmarc Nederland Bv Pharmaceutical composition.
SE9804064D0 (sv) 1998-11-25 1998-11-25 A & Science Invest Ab Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
CA2398255A1 (en) 2000-02-01 2001-08-09 Human Genome Sciences, Inc. Bcl-2-like polynucleotides, polypeptides, and antibodies
GB0111579D0 (en) * 2001-05-11 2001-07-04 Holford & Associates Ltd Oral supplement
CA2500587A1 (en) 2002-10-04 2004-04-22 The Regents Of The University Of California Screening and therapeutic methods relating to neurogenesis
US6969702B2 (en) * 2002-11-20 2005-11-29 Neuronova Ab Compounds and methods for increasing neurogenesis
WO2004045592A2 (en) 2002-11-20 2004-06-03 Neuronova Ab Compounds and methods for increasing neurogenesis
US20040185429A1 (en) 2002-12-09 2004-09-23 Judith Kelleher-Andersson Method for discovering neurogenic agents
US20040254152A1 (en) 2003-04-17 2004-12-16 Monje Michelle L. Prevention of deficits in neurogenesis with anti-inflammatory agents
US7763588B2 (en) 2003-06-13 2010-07-27 The Salk Institute For Biological Studies Method for increasing cognitive function and neurogenesis
WO2005017189A2 (en) 2003-08-05 2005-02-24 University Of Florida Research Foundation, Inc. Neural cell assay
CA2579756C (en) * 2004-06-19 2013-04-30 Human Biomolecular Research Institute Modulators of central nervous system neurotransmitters
ES2702461T3 (es) 2009-03-20 2019-03-01 Hg&H Pharmaceuticals Pty Ltd Extracto de Sceletium y usos del mismo

Also Published As

Publication number Publication date
EP2408446B1 (en) 2019-09-11
DK2408446T3 (da) 2019-12-09
EP2408446A1 (en) 2012-01-25
US20120041045A1 (en) 2012-02-16
ES2759675T3 (es) 2020-05-11
PT2408446T (pt) 2019-12-18
US8552051B2 (en) 2013-10-08
WO2010106494A1 (en) 2010-09-23
ZA201106703B (en) 2012-05-30
AU2010224485B2 (en) 2014-04-17
AU2010224485A1 (en) 2011-10-20

Similar Documents

Publication Publication Date Title
PT2482812T (pt) Composições farmacêuticas compreendendo bi-1356 e metformina
HK1218881A1 (zh) 藥物組合物
ZA201106703B (en) Use of pharmaceutical compositions containing mesembrenone
EP2451274A4 (en) PHARMACEUTICAL COMPOSITIONS
EP2500038A4 (en) PHATMACEUTICAL COMPOSITION FOR EXTERNAL USE /
IL215497A0 (en) Oxadiazile derivatives and pharmaceutical compositions containing them
EP2552447A4 (en) STABLE PHARMACEUTICAL COMPOSITION OF IMATINIB
ZA201203719B (en) Pharmaceutical compositions of sevelamer
ZA201107122B (en) Stable pharmaceutical compositions of diclofenac
EP2515880A4 (en) NEW PHARMACEUTICAL COMPOSITIONS OF RANOLAZINE
ZA201200659B (en) Pharmaceutical composition of isoniazid
PL2391353T3 (pl) Kompozycje farmaceutyczne trimetazydyny
GB0902648D0 (en) Pharmaceutical compounds and compositions
IL219018A (en) Radzolid Pharmaceuticals and Uses
HK1131039A1 (en) Pharmaceutical use of sophoricoside
PL2471520T3 (pl) Kompozycja farmaceutyczna lewetyracetamu
PL2407159T3 (pl) Kompozycje farmaceutyczne olmesartanu
GB0908317D0 (en) Pharmaceutical compounds and compositions
PL2277511T3 (pl) Kompozycje farmaceutyczne lewetiracetamu o przedłużonym uwalnianiu
ZA201200531B (en) Pharmaceutical composition of rifampicin
PL2519261T3 (pl) Płynna kompozycja farmaceutyczna doustna nifedypiny
HU0900698D0 (en) Pharmaceutical compositions of enhanced stability
GB0919055D0 (en) Pharmaceutical compounds and compositions
GB0908069D0 (en) Pharmaceutical compounds and compositions
GB0902651D0 (en) Pharmaceutical compounds and compositions